Menopause and the natural phenomenon of weight gain in middle age make this a topic for primary care physicians to watch.

When you’re on GLP-1 medications that constant nagging about hunger and cravings, also known as “food noise”, finally quiets ...

When you’re on GLP-1 medications that constant nagging about hunger and cravings, also known as “food noise”, finally ...

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

Dr. Heather Rosen By Heather Rosen, PhD Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

Community initiatives played a significant role in distributing food and medicine safely. Local councils were transformed into distribution centres, effectively addressing the needs of residents.

The UK government is working to mitigate potential disruptions to the medicine supply due to tariffs imposed by Donald Trump, which have caused global market instability, according to the health ...

Generally, Medicare does not cover certain medications, such as glucagon-like peptide-1 (GLP-1) receptor agonists, for treating weight loss alone. That said, this may be changing. Currently ...